New translational and clinical biomarker data from Zai Lab’s global oncology program ZL-1211 will be featured in a poster presentation SHANGHAI and CAMBRIDGE, Mass., April 11, 2023 Zai Lab. | April 11, 2023
Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab Full Year and Fourth Quarter 2022 Financial Results Conference Call.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Allogene Therapeutics R&D Showcase Features Hematologic and Solid Tumor Advances Across its AlloCAR T™ Platform streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) – Equities researchers at Oppenheimer increased their FY2022 earnings per share estimates for shares of Allogene Therapeutics in a report released on Tuesday, August 9th. Oppenheimer analyst M. Breidenbach now expects that the company will earn ($2.43) per share for the year, up from their previous forecast of […]